Basic fibroblast growth factor-loaded methacrylate gelatin hydrogel microspheres for spinal nerve regeneration.
Xiaoyan ChenLei RenHui ZhangYangnan HuMenghui LiaoYingbo ShenKaichen WangJiaying CaiHong ChengJiamin GuoYanru QiHao WeiXiaokun LiLuoran ShangJian XiaoJingwu SunRen-Jie ChaiPublished in: Smart medicine (2023)
Spinal cord injury is a severe central nervous system injury, and developing appropriate drug delivery platforms for spinal nerve regeneration is highly anticipated. Here, we propose a basic fibroblast growth factor (bFGF)-loaded methacrylate gelatin (GelMA) hydrogel microsphere with ideal performances for spinal cord injury repair. Benefitting from the precise droplet manipulation capability of the microfluidic technology, the GelMA microspheres possess uniform and satisfactory size and good stability. More importantly, by taking advantage of the porous structures and facile chemical modification of the GelMA microspheres, bFGF could be easily loaded and gradually released. By co-culturing with neural stem cells, it is validated that the bFGF-loaded GelMA microspheres could effectively promote the proliferation and differentiation of neural stem cells. We also confirm the effective role of the bFGF-loaded GelMA microspheres in nerve repair of spinal cord injury in rats. Our results demonstrate the potential value of the microspheres for applications in repairing central nervous system injuries.
Keyphrases
- drug delivery
- spinal cord
- spinal cord injury
- neural stem cells
- wound healing
- cancer therapy
- molecularly imprinted
- stem cells
- neuropathic pain
- drug release
- tissue engineering
- hyaluronic acid
- high throughput
- single cell
- signaling pathway
- cerebrospinal fluid
- highly efficient
- gold nanoparticles
- high resolution
- quantum dots
- simultaneous determination
- tandem mass spectrometry
- human health
- reduced graphene oxide